Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 2-3
170
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Analysis of Toll-Like Receptor-2 and 4 Expressions in Peripheral Monocyte Subsets in Patients with Type 1 Diabetes Mellitus

, ORCID Icon, , , , , & show all

References

  • Ahmad R, Al-Mass A, Atizado V, Al-Hubail A, Al-Ghimlas F, Al-Arouj M, Bennakhi A, Dermime S, Behbehani K. 2012. Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation. J Inflamm (Lond). 9(1):48.
  • Akbari M, Hassan-Zadeh V. 2018. Hyperglycemia affects the expression of inflammatory genes in peripheral blood mononuclear cells of patients with type 2 diabetes. Immunol Invest. 47(7):654–65.
  • Auffray C, Sieweke MH, Geissmann F. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 27(1):669–92.
  • Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, Espevik T, Ziegler-Heitbrock L. 2002. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 168(7):3536–42.
  • Cejkova P, Nemeckova I, Broz J, Cerna M. 2016. TLR2 and TLR4 expression on CD14++ and CD14+ monocyte subtypes in adult-onset autoimmune diabetes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 160(1):76–83.
  • Cerna M, Kolostova K, Novota P, Romzova M, Cejkova P, Pinterova D, Pruhova S, Treslova L, Andel M. 2007. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions. Ann N Y Acad Sci. 1110(1):140–50.
  • Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, et al. 2010. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 33(3):375–86.
  • Dasu MR, Devaraj S, Park S, Jialal I. 2010. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 33(4):861–68.
  • Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. 2008. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 57(11):3090–98.
  • Devaraj S, Dasu MR, Park SH, Jialal I. 2009. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia. 52(8):1665–68.
  • Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. 2008. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 93(2):578–83.
  • Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A, Jialal I. 2011. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol. 31(8):1796–804.
  • El-Ziny MA, Salem NA, El-Hawary AK, Chalaby NM, Elsharkawy AA. 2014. Epidemiology of childhood type 1 diabetes mellitus in Nile Delta, northern Egypt - a retrospective study. J Clin Res Pediatr Endocrinol. 6:9–15.
  • Grosse J, Hornstein H, Manuwald U, Kugler J, Glauche I, Rothe U. 2018. Incidence of diabetic ketoacidosis of new-onset type 1 diabetes in children and adolescents in different countries correlates with Human Development Index (HDI): an updated systematic review, meta-analysis, and meta-regression. Horm Metab Res. 50(03):209–22.
  • Hill HR, Hogan NA, Rallison ML, Santos JI, Charette RP, Kitahara M. 1982. Functional and metabolic abnormalities of diabetic monocytes. Adv Exp Med Biol. 141:621–28.
  • Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H. 2004. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 50(5):1457–67.
  • Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. 2007. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab. 92(9):3705–11.
  • Karananou P, Fleva A, Tramma D, Alataki A, Pavlitou-Tsiontsi A, Emporiadou-Peticopoulou M, Papadopoulou-Alataki E. 2016. Altered expression of TLR2 and TLR4 on peripheral CD14+ blood monocytes in children with urinary tract infection. Biomed Res Int. (2016:6052891.
  • Kim HS, Han MS, Chung KW, Kim S, Kim E, Kim MJ, Jang E, Lee HA, Youn J, Akira S, et al. 2007. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity. 27(2):321–33.
  • Lin M, Yiu WH, Li RX, Wu HJ, Wong DW, Chan LY, Leung JC, Lai KN, Tang SC. 2013. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int. 83(5):887–900.
  • Mehta NN, Reilly MP. 2012. Monocyte mayhem: do subtypes modulate distinct atherosclerosis phenotypes? Circ Cardiovasc Genet. 5(1):7–9.
  • Mobley JL, Leininger M, Madore S, Baginski TJ, Renkiewicz R. 2007. Genetic evidence of a functional monocyte dichotomy. Inflammation. 30(6):189–97.
  • Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun Y, Grafenstein H, Hong SC, McInerney MF. 2006. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol. 18(7):1101–13.
  • Sabbah E, Savola K, Ebeling T, Kulmala P, Vahasalo P, Ilonen J, Salmela PI, Knip M. 2000. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care. 23(9):1326–32.
  • Singh A, Boden G, Rao AK. 2015. Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus. Thromb Haemost. 113(04):750–58.
  • Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, Pryjma J. 2008. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol. 67:152–59.
  • Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol. 21(1):335–76.
  • Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell. 140(6):805–20.
  • Ururahy MA, Loureiro MB, Freire-Neto FP, de Souza KS, Zuhl I, Brandao-Neto J, Hirata RD, Doi SQ, Arrais RF, Hirata MH, et al. 2012. Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria. Pediatr Diabetes. 13:147–54.
  • Vuckovic S, Withers G, Harris M, Khalil D, Gardiner D, Flesch I, Tepes S, Greer R, Cowley D, Cotterill A, et al. 2007. Decreased blood dendritic cell counts in type 1 diabetic children. Clin Immunol. 123(3):281–88.
  • Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ. 2008. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol. 180(3):1929–37.
  • Ziegler-Heitbrock L. 2007. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 81(3):584–92.
  • Zipris D. 2008. Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 15(4):326–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.